AAAAAA

   
Results: 1-17 |
Results: 17
SEQUENCE EFFECT OF IRINOTECAN (CPT-11) AND TOPOISOMERASE-II INHIBITORS IN-VIVO
Authors: EDER JP CHAN V WONG J WONG YW ARA G NORTHEY D RIZVI N TEICHER BA
Citation: Jp. Eder et al., SEQUENCE EFFECT OF IRINOTECAN (CPT-11) AND TOPOISOMERASE-II INHIBITORS IN-VIVO, Cancer chemotherapy and pharmacology, 42(4), 1998, pp. 327-335
LISOFYLLINE AS AN ADJUVANT TO HIGH-DOSE CYTOTOXIC THERAPY
Authors: TEICHER BA KAKEJI Y NORTHEY D
Citation: Ba. Teicher et al., LISOFYLLINE AS AN ADJUVANT TO HIGH-DOSE CYTOTOXIC THERAPY, International journal of oncology, 11(2), 1997, pp. 265-272
INTERACTION OF INTERLEUKIN-11 (RHIL-11) WITH CYTOTOXIC THERAPIES IN THE HUMAN HT-29 COLON-CARCINOMA
Authors: TEICHER BA ARA G NORTHEY D
Citation: Ba. Teicher et al., INTERACTION OF INTERLEUKIN-11 (RHIL-11) WITH CYTOTOXIC THERAPIES IN THE HUMAN HT-29 COLON-CARCINOMA, International journal of oncology, 10(6), 1997, pp. 1081-1085
HOST DISTRIBUTION AND RESPONSE TO ANTITUMOR ALKYLATING-AGENTS OF EMT-6 TUMOR-CELLS FROM SUBCUTANEOUS TUMOR IMPLANTS
Authors: HOLDEN SA EMI Y KAKEJI Y NORTHEY D TEICHER BA
Citation: Sa. Holden et al., HOST DISTRIBUTION AND RESPONSE TO ANTITUMOR ALKYLATING-AGENTS OF EMT-6 TUMOR-CELLS FROM SUBCUTANEOUS TUMOR IMPLANTS, Cancer chemotherapy and pharmacology, 40(1), 1997, pp. 87-93
TNP-470 MINOCYCLINE/CYTOTOXIC THERAPY - A SYSTEMS-APPROACH TO CANCER-THERAPY/
Authors: TEICHER BA EMI Y KAKEJI Y NORTHEY D
Citation: Ba. Teicher et al., TNP-470 MINOCYCLINE/CYTOTOXIC THERAPY - A SYSTEMS-APPROACH TO CANCER-THERAPY/, European journal of cancer, 32A(14), 1996, pp. 2461-2466
TISSUE DISTRIBUTION OF LYCOPENE ISOMERS IN NUDE-MICE BEARING IMPLANTSOF HUMAN PROSTATE ADENOCARCINOMA
Authors: CLINTON SK WILLIAMS AW BOILEAU TW ZHOU JR NORTHEY D TEICHER B ERDMAN JW
Citation: Sk. Clinton et al., TISSUE DISTRIBUTION OF LYCOPENE ISOMERS IN NUDE-MICE BEARING IMPLANTSOF HUMAN PROSTATE ADENOCARCINOMA, The FASEB journal, 10(3), 1996, pp. 1392-1392
INTERACTION OF INTERLEUKIN-11 WITH CYTOTOXIC THERAPIES IN-VITRO AGAINST CEM CELLS AND IN-VIVO AGAINST EMT-6 MURINE MAMMARY-CARCINOMA
Authors: TEICHER BA CHEN YN ARA G EMI Y KAKEJI Y MAEHARA Y KEYES S NORTHEY D
Citation: Ba. Teicher et al., INTERACTION OF INTERLEUKIN-11 WITH CYTOTOXIC THERAPIES IN-VITRO AGAINST CEM CELLS AND IN-VIVO AGAINST EMT-6 MURINE MAMMARY-CARCINOMA, International journal of cancer, 67(6), 1996, pp. 864-870
HIGH-DOSE THERAPY STEM-CELL SUPPORT - COMPARISON OF MICE AND HUMANS
Authors: TEICHER BA NORTHEY D YUAN J FREI E
Citation: Ba. Teicher et al., HIGH-DOSE THERAPY STEM-CELL SUPPORT - COMPARISON OF MICE AND HUMANS, International journal of cancer, 65(5), 1996, pp. 695-699
ANTIFOLATES CAN POTENTIATE TOPOISOMERASE-II INHIBITORS IN-VITRO AND IN-VIVO
Authors: HOLDEN SA TEICHER BA ROBINSON MF NORTHEY D ROSOWSKY A
Citation: Sa. Holden et al., ANTIFOLATES CAN POTENTIATE TOPOISOMERASE-II INHIBITORS IN-VITRO AND IN-VIVO, Cancer chemotherapy and pharmacology, 36(2), 1995, pp. 165-171
CYCLOCREATINE IN CANCER-CHEMOTHERAPY
Authors: TEICHER BA MENON K NORTHEY D LIU J KUFE DW KADDURAHDAOUK R
Citation: Ba. Teicher et al., CYCLOCREATINE IN CANCER-CHEMOTHERAPY, Cancer chemotherapy and pharmacology, 35(5), 1995, pp. 411-416
MOLECULAR CHARACTERIZATION OF THE IN-VIVO ALKYLATING AGENT RESISTANT MURINE EMT-6 MAMMARY-CARCINOMA TUMORS
Authors: CHATTERJEE D LIU CJT NORTHEY D TEICHER BA
Citation: D. Chatterjee et al., MOLECULAR CHARACTERIZATION OF THE IN-VIVO ALKYLATING AGENT RESISTANT MURINE EMT-6 MAMMARY-CARCINOMA TUMORS, Cancer chemotherapy and pharmacology, 35(5), 1995, pp. 423-431
OXYGENATION OF HUMAN TUMOR XENOGRAFTS IN NUDE-MICE BY A PERFLUOROCHEMICAL, EMULSION AND CARBOGEN BREATHING
Authors: TEICHER BA SCHWARTZ GN DUPUIS NP KUSOMOTO T LIU M LIU F NORTHEY D
Citation: Ba. Teicher et al., OXYGENATION OF HUMAN TUMOR XENOGRAFTS IN NUDE-MICE BY A PERFLUOROCHEMICAL, EMULSION AND CARBOGEN BREATHING, Artificial cells, blood substitutes, and immobilization biotechnology, 22(4), 1994, pp. 1369-1375
MODULATION OF [CIS-DIAMINEDICHLOROPLATINUM(II) HYPERTHERMIA] THERAPY BY INHIBITORS OF ARACHIDONIC-ACID METABOLISM
Authors: TEICHER BA HOLDEN SA HERMAN TS NORTHEY D
Citation: Ba. Teicher et al., MODULATION OF [CIS-DIAMINEDICHLOROPLATINUM(II) HYPERTHERMIA] THERAPY BY INHIBITORS OF ARACHIDONIC-ACID METABOLISM, International journal of oncology, 4(1), 1994, pp. 17-22
CAI - EFFECTS ON CYTOTOXIC THERAPIES IN-VITRO AND IN-VIVO
Authors: TEICHER BA HOLDEN SA CHEN YN ARA G KORBUT TT NORTHEY D
Citation: Ba. Teicher et al., CAI - EFFECTS ON CYTOTOXIC THERAPIES IN-VITRO AND IN-VIVO, Cancer chemotherapy and pharmacology, 34(6), 1994, pp. 515-521
IN-VIVO MODULATION OF SEVERAL ANTICANCER AGENTS BY BETA-CAROTENE
Authors: TEICHER BA SCHWARTZ JL HOLDEN SA ARA G NORTHEY D
Citation: Ba. Teicher et al., IN-VIVO MODULATION OF SEVERAL ANTICANCER AGENTS BY BETA-CAROTENE, Cancer chemotherapy and pharmacology, 34(3), 1994, pp. 235-241
THERAPEUTIC EFFECT OF INFUSED FLUOSOL-DA CARBOGEN WITH EPHEDRINE, FLUNARIZINE, OR NITROPRUSSIDE
Authors: TEICHER BA HOLDEN SA NORTHEY D DEWHIRST MW HERMAN TS
Citation: Ba. Teicher et al., THERAPEUTIC EFFECT OF INFUSED FLUOSOL-DA CARBOGEN WITH EPHEDRINE, FLUNARIZINE, OR NITROPRUSSIDE, International journal of radiation oncology, biology, physics, 26(1), 1993, pp. 103-109
RESPONSE OF THE FSAII FIBROSARCOMA TO ANTIANGIOGENIC MODULATORS PLUS CYTOTOXIC AGENTS
Authors: TEICHER BA HOLDEN SA ARA G NORTHEY D
Citation: Ba. Teicher et al., RESPONSE OF THE FSAII FIBROSARCOMA TO ANTIANGIOGENIC MODULATORS PLUS CYTOTOXIC AGENTS, Anticancer research, 13(6A), 1993, pp. 2101-2106
Risultati: 1-17 |